Yes. Senegal, South Africa, Egypt, Tunisia and Morocco are the only African countries with some vaccine manufacturing capacity.

For more African countries to develop these capabilities, we need more international cooperation and greater sharing of expertise.

With flexibility around technology transfer and the waiving of intellectual property rights during the pandemic, investment in African countries could start by focusing on filling and packaging COVID-19 vaccines. From this, further investment could help build up more complex capacities for manufacturing and research and development.

More detailed information on vaccine manufacturing capacity in Africa can be found here.